About
Oculis Holding Ag — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
May 5 2026
Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting
Apr 20 2026
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema
Mar 31 2026
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
Mar 16 2026
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
Recent Videos

OCS Stock Analysis | Oculis Holding AG | May 5, 2026
May 04, 2026

Oculis révolutionne les injections ophtalmiques par des gouttes innovantes
Apr 14, 2026

Discover the news scale-up : OCULIS
Apr 13, 2026

Grow Your Business with the Right Revenue Attribution software
Mar 30, 2026
Translate